Risks

Higher leverage than many insurance brokers leaves MRSH more exposed than asset-light peers if financing costs stay elevated, pressuring valuation and flexibility.

A current ratio near 1.1 versus stronger liquidity at larger diversified brokers limits cushion against working-capital shocks, increasing downside in a softer placement cycle.

Days sales outstanding above 116 days suggests slower cash collection than peers, which can amplify liquidity strain if client payment timing worsens.

Interest coverage around 6.3x is adequate but below top-tier broker peers, so earnings volatility could more quickly constrain capital deployment in a downturn.

Opportunities

Marsh McLennan’s scale and diversified risk-advisory platform support steadier demand than smaller brokers, helping it capture share when clients prioritize resilience and expertise.

The company’s brokerage and consulting mix is better positioned than pure-play intermediaries to benefit from sustained demand for complex risk transfer and advisory services.

Global client relationships and broad product breadth give MRSH more cross-sell potential than regional peers, supporting organic growth even in slower insurance pricing environments.

Its relatively stable cash generation profile versus more cyclical financial intermediaries should help preserve investment capacity for talent, technology, and client retention.

Overall Score

MRSH’s forward positioning is supported by scale, diversification, and cross-sell opportunities, while leverage, liquidity, and collection timing remain manageable but meaningful peer-relative risks.